Category Archives: Corporate

Unknown Kentucky biotech Bexion tests new glioma med on first patients. Yes, it’s the same cancer Sen. McCain is fighting, and Round B funding is still open.

The News: Bexion Pharmaceuticals burst out of the shadows of near total obscurity last week as its investigational cancer treatment, BXQ-350, grabbed plenty of mainstream media coverage as a potential game-changer. BXQ-350 is… Read more »

Move over, Nasdaq: BeiGene’s mammoth IPO in Hong Kong sends message to biotech startups.

The News: Nasdaq-listed Chinese biotech BeiGene Ltd. (Beijing) has raised an astounding $903 million after pricing its secondary listing in Hong Kong–the first under new exchange rules–near the top of… Read more »

Healthcare IPOs defy gravity and second law of thermodynamics with 8 new pricings last week and 2 new filings.

Well, here we are again, looking back at another massive round of biotech IPOs priced just last week, as the beat goes on and on and… My trusty, hand-held calculator… Read more »

Vertex says it would be NICE if England upped its offer for new CF drugs. Meanwhile, short lesson on how US could quickly lower its pharma prices, too.

The News: Vertex Pharma CEO Jeffrey Leiden’s move earlier this month to pressure England’s prime minister Theresa May on drug prices seems to have set some wheels in motion. After… Read more »

Top 1H health-sector winners and losers; buy/sell opinion.

The News: Now that we’ve reached the end of the first half of 2018, there might be some interesting surprises–both good and not-so-good–for those equity investors interested in who’s being… Read more »

2018 biotech IPOs still on a tear, with 25 already priced; 8 new filings last week alone.

In all my 26 years at MondayMorning, never have I witnessed such a massive, mad dash for the IPO filing window, and the SEC must be wondering if and when… Read more »

Elizabeth Holmes’ partner in blood-fraud scheme largely anonymous. Theranos–the Movie–already in the works.

The News: Theranos, the humiliated, disintegrating, and allegedly fraud- packed blood-testing startup, is most often related to its founder and CEO, Elizabeth Holmes. But during the rise and fall of… Read more »

Weekly Medical Stock Spotlight: Group still outperforming other sectors. My take.

All three major US stock indices posted a weekly loss last week as the markets reacted to reports from the US-China trade summit, rising US government bond yields and increasing… Read more »